Photo: Eve Edelheit/The WA Post/Getty Images |
Are you ready for woke death panels?
The federal government currently controls the market of monoclonal antibodies that are used to treat cases of the coronavirus and regulates the supply allocated to the states. Monoclonal antibodies are effective treatments and in some cases are literal lifesavers.
Some state leaders, like Florida Gov. Ron DeSantis, have requested that the federal government release its control of the market, which in many places has been unable to keep up with demand.
So far, President Joe Biden’s administration hasn’t budged. And what do we get for the federal government’s role in this treatment’s distribution?
Racialized eligibility requirements.
The New York City Department of Health and Mental Hygiene made news when it issued guidance on its website at the beginning of the year that it would consider race when determining who would be given the potentially lifesaving COVID-19 treatments. --->READ MORE HEREFDA wants race, ethnicity factored in administering COVID drugs:
The Food and Drug Administration is urging health care providers to consider race or ethnicity as well as underlying medical conditions when classifying individuals as “high risk for progression to severe COVID-19″ and qualifying for antibody treatment.
A fact sheet issued by the agency detailing the emergency use authorization of the drug sotrovimab for treatment of mild to moderate COVID-19 cases includes a list of medical conditions that may qualify patients for the treatment.
Those conditions include advanced age (65 or older), obesity, pregnancy, diabetes, cardiovascular disease, chronic lung disease, and neurodevelopmental disorders.
The document, which was last updated in December, also notes that “[o]ther medical conditions or factors (for example, race or ethnicity) may also place individual patients at high risk for progression to severe COVID-19.”
As the treatment is specified as being for mild to moderate cases, it is not authorized for patients who are hospitalized because of COVID-19, require oxygen therapy due to the virus, or require an increase in oxygen flow --->READ MORE HEREFollow links below to related stories and resources:
+++++Biden Admin Quietly Creates Creepy Database Storing Information About Unvaxxed People Who Request Religious Exemptions+++++
COVID loses 50% of ability to infect after 10 seconds in office air: study
USA TODAY: Coronavirus Updates
WSJ: Coronavirus Live Updates
YAHOO NEWS: Coronavirus Live Updates
NEW YORK POST: Coronavirus The Latest
If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.
No comments:
Post a Comment